7 sources • 4 verified points
AstraZeneca and Oracle Launch Global AI Collaboration to Advance Clinical Trials
AstraZeneca and Oracle Health and Life Sciences announced a collaboration to combine AstraZeneca's scientific and clinical expertise with Oracle's technologies to advance AI-powered clinical trials. Reports indicate the collaboration focuses on recruiting patients for trials and accelerating their screening, and that it is launching from Abu Dhabi.
AI-written summary of 7 sources; every verified point is backed by a verbatim quote. How Iyan works
- The announcement was issued by AstraZeneca and Oracle Health and Life Sciences, and draws on AstraZeneca's scientific and clinical expertise alongside Oracle's technologies.
«AstraZeneca and Oracle Health and Life Sciences today announced a unique collaboration to leverage AstraZeneca's scientific, clinical development and»
Mirage News - Oracle's collaboration with AstraZeneca may open the door to healthcare AI resembling software, with recurring revenue, and includes Cerner upgrades, patient enrollment in trials, and care pathways.
«The AstraZeneca collaboration is a credible wedge into recurring, software-like healthcare AI (Cerner upgrades + trial recruitment + care pathways).»
Invezz - Coverage reported that the global collaboration in healthcare AI is launching from Abu Dhabi.
«AstraZeneca and Oracle Launch Global Healthcare AI Collaboration Starting in Abu Dhabi»
Konsulteer - Reports said Oracle will help improve patient recruitment for clinical trials and accelerate their screening.
«Oracle Teams Up with AstraZeneca to Deploy AI, Aiming to Speed Up Patient Screening for Clinical Trials»
Fierce Biotech • BigGo Finance
Iyan — See it for yourself. What changed in your world today, why it matters, and how we know.
How it works • Privacy • Terms